GlobeNewswire Inc | Feb 11, 2021 10:00AM EST

February 11, 2021

FARMINGDALE, N.Y., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc.(NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that Misonix Chief Executive Officer, Stavros Vizirgianakis, along with Joe Dwyer, Chief Financial Officer, will be participating in two upcoming investor conferences.

-- BTIG Virtual MedTech, Digital Health, Life Science & Diagnostics Tools ConferenceDates: February 17th and 18thManagement will host a presentation on Wednesday, February 17th at 2:00 p.m. EST

-- 10th Annual SVB Leerink Global Healthcare ConferenceDates: February 24th, 25th and 26thManagement will host a fireside chat on Friday, February 26th at 8:00 a.m. EST

For more information about the conferences or to schedule a virtual one-on-one meeting with management, please contact your conference representative. Alternatively, please contact Misonixs investor relations atmson@jcir.com.

About Misonix, Inc.Misonix, Inc. (Nasdaq: MSON) is a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative tissue products. Its surgical team markets and sells BoneScalpel and SonaStar, which facilitate precise bone sculpting and removal of soft and hard tumors and tissue, primarily in the areas of neurosurgery, orthopedic, plastic and maxillo-facial surgery. The Company's wound team markets and sells TheraSkin, Therion, TheraGenesis and SonicOne to debride, treat and heal chronic and traumatic wounds in inpatient, outpatient and physician office sites of service. At Misonix, Better Matters! That is why throughout the Companys history, Misonix has maintained its commitment to medical technology innovation and the development of products that radically improve outcomes for patients. Additional information is available on the Company's web site at www.misonix.com.

Contact: Joe Dwyer Norberto Aja, Jennifer NeumanChief Financial Officer JCIRMisonix, Inc. 212-835-8500 or mson@jcir.com631-927-9113